Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahn, B.
Right arrow Articles by Ohshima, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahn, B.
Right arrow Articles by Ohshima, H.
[Cancer Research 61, 8357-8360, December 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Suppression of Intestinal Polyposis in ApcMin/+ Mice by Inhibiting Nitric Oxide Production

Byeongwoo Ahn and Hiroshi Ohshima1

Department of Pathology, National Institute of Toxicological Research, Korea Food and Drug Administration, Seoul, 122-704, Korea [B. A.], and Unit of Endogenous Cancer Risk Factors, International Agency for Research on Cancer, 69372, Lyon, Cedex 08, France [H. O.]

Inducible nitric oxide synthase (iNOS) was shown to be expressed in normal mucosa and adenoma of small and large intestines of ApcMin/+ mice by reverse transcription-PCR and immunohistochemistry. Administration of the iNOS inhibitor aminoguanidine (1.5 g/liter) in drinking water or an L-arginine-deficient diet to ApcMin/+ mice resulted in a significant decrease in adenoma development in the small but not the large intestine. Similarly, iNOS-gene knockout ApcMin/+ mice (ApcMin/+ iNOS-/- or ApcMin/+ iNOS-/+) developed significantly fewer adenomas in both small and large intestines than ApcMin/+ iNOS+/+ mice. These results suggest that iNOS-selective inhibitors could be used as a potential chemopreventive agent for colorectal cancers.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. E. Erdman, V. P. Rao, T. Poutahidis, A. B. Rogers, C. L. Taylor, E. A. Jackson, Z. Ge, C. W. Lee, D. B. Schauer, G. N. Wogan, et al.
Nitric oxide and TNF-{alpha} trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice
PNAS, January 27, 2009; 106(4): 1027 - 1032.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Zhang, A. Ma, S. J. Urbanski, and D.-M. McCafferty
Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma
Carcinogenesis, May 1, 2007; 28(5): 1122 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Stempelj, M. Kedinger, L. Augenlicht, and L. Klampfer
Essential Role of the JAK/STAT1 Signaling Pathway in the Expression of Inducible Nitric-oxide Synthase in Intestinal Epithelial Cells and Its Regulation by Butyrate
J. Biol. Chem., March 30, 2007; 282(13): 9797 - 9804.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Chen, Y. Yan, J. Li, Q. Ma, G. D. Stoner, J. Ye, and C. Huang
Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells
Carcinogenesis, June 1, 2005; 26(6): 1035 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. H. Itzkowitz and X. Yio
Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G7 - G17.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Ikezoe, Y. Yang, D. Heber, H. Taguchi, and H. P. Koeffler
PC-SPES: A Potent Inhibitor of Nuclear Factor-{kappa}B Rescues Mice from Lipopolysaccharide-Induced Septic Shock
Mol. Pharmacol., December 1, 2003; 64(6): 1521 - 1529.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Dhar, J. M. Brindley, C. Stark, M. L. Citro, L. K. Keefer, and N. H. Colburn
Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Mol. Cancer Ther., December 1, 2003; 2(12): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Galli, M. I. Labato, E. Bal de Kier Joffe, M. C. Carreras, and J. J. Poderoso
Decreased Mitochondrial Nitric Oxide Synthase Activity and Hydrogen Peroxide Relate Persistent Tumoral Proliferation to Embryonic Behavior
Cancer Res., October 1, 2003; 63(19): 6370 - 6377.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. A. Crowell, V. E. Steele, C. C. Sigman, and J. R. Fay
Is Inducible Nitric Oxide Synthase a Target for Chemoprevention?
Mol. Cancer Ther., August 1, 2003; 2(8): 815 - 823.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. E. Corpet and F. Pierre
Point: From Animal Models to Prevention of Colon Cancer. Systematic Review of Chemoprevention in Min Mice and Choice of the Model System
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 391 - 400.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Klatt and M. Serrano
Engineering cancer resistance in mice
Carcinogenesis, May 1, 2003; 24(5): 817 - 826.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Q. Liu, S.T.F. Chan, and R. Mahendran
Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines
Carcinogenesis, April 1, 2003; 24(4): 637 - 642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, N. Schiavone, A. Vannacci, S. Nistri, I. Sardi, G. Baroni, C. Marzocca, et al.
Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer: Correlation with Tumor Angiogenesis
Am. J. Pathol., March 1, 2003; 162(3): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. R. Kisley, B. S. Barrett, A. K. Bauer, L. D. Dwyer-Nield, B. Barthel, A. M. Meyer, D. C. Thompson, and A. M. Malkinson
Genetic Ablation of Inducible Nitric Oxide Synthase Decreases Mouse Lung Tumorigenesis
Cancer Res., December 1, 2002; 62(23): 6850 - 6856.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. M. Mei, G. L. Borchert, S. P. Donald, and J. M. Phang
Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of {beta}-catenin from membrane bound E-cadherin and formation of nuclear {beta}-catenin/LEF-1 complex
Carcinogenesis, December 1, 2002; 23(12): 2119 - 2122.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. P. Femia, C. Luceri, P. Dolara, A. Giannini, A. Biggeri, M. Salvadori, Y. Clune, K. J. Collins, M. Paglierani, and G. Caderni
Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats
Carcinogenesis, November 1, 2002; 23(11): 1953 - 1960.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.